Concepedia

The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates

Stefany Acosta‐Torres, Tricia Murdock, Rayna K. Matsuno, Anna Beavis, Rebecca L. Stone, Stephanie L. Wethington, Kimberly Levinson, Francis C. Grumbine, J. Stuart Ferriss, Edward J. Tanner,

Gynecologic Oncology · 2020 · 42 citations · 14 references

DOI

Concepts

References

14

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant et al. · Annals of Oncology · 2015 · 1.4K citations · Full text

, , +14

International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013

Joannie Lortet‐Tieulent, Jacques Ferlay, Freddie Bray et al. · JNCI Journal of the National Cancer Institute · 2017 · 790 citations · Full text

, , +13

Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

Wui-Jin Koh, Nadeem R. Abu‐Rustum, Sarah Bean et al. · Journal of the National Comprehensive Cancer Network · 2018 · 657 citations · Full text

, , +11

Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy

Leigh A. Cantrell, Chunxiao Zhou, Alberto A. Mendivil et al. · Gynecologic Oncology · 2009 · 332 citations

, , +11

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells

Ya Xie, Yanling Wang, Li‐Rong Yu et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2010 · 144 citations

, , +15